Extended-spectrum β-lactamases (ESBLs) are an increasing challenge in the treatment of urinary tract infections (UTIs), and also in the community. We aimed to investigate the characteristics of patients with UTIs due to ESBL-producing Escherichia coli and to assess the risk factors for ESBLs in community-acquired isolates. We performed a retrospective study from January 1, 27 to December 31, 29 at a tertiary care teaching hospital in Switzerland, comparing patients with community-acquired versus healthcare-associated UTIs due to ESBL-producing E. coli. Additionally, we investigated the antimicrobial susceptibility of these isolates. A total of 123 patients were studied, of whom 79 (64%) had community-acquired and 44 (36%) had healthcare-associated UTIs. Community-acquired isolates were associated with acute uncomplicated UTIs (odds ratio [OR] 6.62, 95% confidence interval 1.83–36.5, P < .1). Risk factors were recurrent UTI (OR 3.4, 95% CI 1.14–9.14, P = .22) and female sex (OR 2.46, 95% CI 1.1–6.8). Community-acquired ESBL-producing E. coli urinary isolates showed high resistance rates to most of the currently used oral antimicrobial agents, including β-lactam antibiotics (amoxicillin–clavulanic acid, 69.6% resistance), quinolones (ciprofloxacin, 84.8% resistance; norfloxacin, 83.9% resistance), and trimethoprim–sulfamethoxazole (75.9% resistance), except for nitrofurantoin (15% resistance) and fosfomycin (% resistance). UTI due to ESBL-producing E. coli are emerging, and also in a country with low antibiotic use. Because of increasing antibiotic resistance rates of E. coli to current standard therapy and because of the resistance patterns of ESBL-producing E. coli, guidelines for the management of UTIs must be revised. Fosfomycin or nitrofurantoin are recommended for the first-line empirical oral treatment of community-acquired uncomplicated UTIs.
Related Content
Resistance surveillance studies: a multifaceted problem—the fluoroquinolone example
This review summarizes data on the fluoroquinolone resistance epidemiology published in the previous 5 years. The data reviewed are stratified according to the different prescription patterns by either primary- or tertiary-care givers and by indication. Global surveillance studies demonstrate tha...


Analysis of the spectrum and antibiotic resistance of uropathogens in vitro: Results based on a retrospective study from a tertiary hospital
Antibiotic resistance of uropathogens in urinary tract infections (UTIs) is increasing worldwide. This study aimed to compare the spectrum and antimicrobial resistance of uropathogens in community-acquired UTIs (CAUTIs) and nosocomial-acquired UTIs (NAUTIs) at a tertiary hospital in China. Retros...
Prevalence of urinary colonization by extended spectrum-beta-lactamase Enterobacteriaceae among catheterised inpatients in Italian long term care facilities
Long Term Care Facilities (LTCFs) play a key role in guaranteeing care to patients in developed countries. Many patients, mostly elderly, access LTCFs at some time in their lives, and their healthcare pathways often require them to move back and forth between hospital and outpatient settings. The...


Increasing prevalence of ESBL production among Irish clinical Enterobacteriaceae from 24 to 28: an observational study
Extended spectrum β-lactamase (ESBL) producing Enterobacteriaceae infections are associated with delayed initiation of appropriate treatment, poor outcomes and increased hospital stay and expense. Although initially associated with healthcare settings, more recent international reports have show...
Increasing prevalence of ESBL production among Irish clinical Enterobacteriaceae from 24 to 28: an observational study
Extended spectrum beta-lactamase (ESBL) producing Enterobacteriaceae infections areassociated with delayed initiation of appropriate treatment, poor outcomes and increasedhospital stay and expense. Although initially associated with healthcare settings, more recentinternational reports have shown...

ΓδT cells suppress inflammation and disease during rhinovirus-induced asthma exacerbations
Most asthma exacerbations are triggered by virus infections, the majority being caused by human rhinoviruses (RV). In mouse models, γδT cells have been previously demonstrated to influence allergen-driven airways hyper-reactivity (AHR) and can have antiviral activity, implicating ...
Céfoxitine, seconde jeunesse ?
La céfoxitine est un antibiotique de la classe des céphamycines dont le spectre d’action se rapproche des céphalosporines de deuxième génération, avec une activité sur les bacilles à Gram négatif anaérobies. Remplacée dans la plupart de ses indications par les céphalosporines de tro...

CTX-M-producing Escherichia coli and Klebsiella pneumoniae isolated from community-acquired urinary tract infections in Valledupar, Colombia
Describe the presence of CTX-M-1 phylogenetic subgroup extended-spectrum β-lactamases (ESBL), associated with TEM and SHV genes, and the gene encoding cephalosporinase, CMY-2 in Escherichia coli and Klebsiella pneumoniae isolates from community acquired urinary tract infections. 102 E. coli and ...
Identifying Patients Harboring Extended-Spectrum-beta-Lactamase-Producing Enterobacteriaceae on Hospital Admission: Derivation and Validation of a Scoring System
Increases in community-acquired infections caused by extended-spectrum-β-lactamase (ESBL)-producing Enterobacteriaceae have important implications for hospital infection control and empirical antibiotic therapy protocols. We developed and validated a tool for identifying patients harboring t...

Frequency of extended-spectrum β-lactamase (ESBL)-producing Gram-negative bacilli in a 2-bed multi-specialty hospital in Vellore district, Tamil Nadu, India
Extended-spectrum β-lactamase (ESBL) producers were reported only from hospital settings previously, but, nowadays, its common presence in community settings is evident from reports. Our primary aim was to assess the frequency of ESBL-producing Gram-negative bacteria (GNB) and their antibiogram ...